Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: A prospective study comparing anti-nucleosome with anti-dsDNA antibodies

Journal of Rheumatology

Volumn 33, Issue 8, 2006, Pages 1538-1544

  Gutiérrez Adrianzén, Oswaldo Augusto ^a,c   Koutouzov, Sophie ^b   Salani Mota, Rosa Maria ^a   Das Chagas Medeiros, Marta Maria ^a   Bach, Jean François ^b   De Holanda Campos, Henry ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b INSERM   (France)

^c Institut Nationale de la Santé et de la Recherche Médicale ^*  (Brazil)

Author keywords

Anti dsDNA antibodies; Anti nucleosome antibodies; Disease activity; Lupus nephritis; Systemic lupus erythematosus

Indexed keywords

DOUBLE STRANDED DNA ANTIBODY; NUCLEOSOME ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY TEST; LUPUS ACTIVITY CRITERIA COUNT; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX;

EID: 33746729488     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Matsumoto K, Osakabe K, Ohi H, Yoshizawa N, Harada M, Hatano M. Alteration of T-lymphocyte subpopulations in patients with primary renal diseases and systemic lupus erythematosus. Scand J Immunol 1980;11:187-93.
2. Berden JHM. Lupus nephritis. Nephrology Forum. Kidney Int 1997;52:538-58.
3. Spronk PE, ter Borg EJ, Huitema MG, Limburg PC, Kallenberg CG. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 1994;53:235-59.
4. Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology Oxford 2001;40:1405-12.
5. Madaio MP, Hodder S, Schwartz RS, Stollar BD. Responsiveness of autoimune and normal mice to nucleic acid antigens. J Immunol 1984;132:872-6.
6. Amoura Z, Chabre H, Bach JF, Jacob L. The appearance of anti-nucleosome antibodies precedes that of anti-double-stranded DNA and anti-histones in urine lupus. Rev Med Interne 1993;14:980.
7. Amoura Z, Koutousov S, Piette JC. The role of nucleosomes in lupus. Curr Opin Rheumatol 2000;12:369-73.
8. Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum 2000;43:2307-15.
9. Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JP. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolysaccharide administration. Arthritis Rheum 2001;44:1320-30.
10. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome, a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993;177:1367-81.
11. Burlingame RW, Rubin RL, Balderas RS, Theofilopoulos NA. Genesis and evolution of anti-chromatin autoantibodies in murine lupus implicates T-dependent immunization with self-antigen. J Clin Invest 1993;91:1687-96.
12. Amoura Z, Chabre H, Koutouzouv S, et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 1994;37:1684-8.
13. Kramers C, Hylkema MN, van Bruggen MCJ, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 1994;94:568-77.
14. van Bruggen MCJ, Kramers C, Hylkema MN, Smeenk RJ, Berden JH. Significance of anti-nuclear and anti-extra cellular matrix autoantibodies for albuminuria in MRL/1 mice. A longitudinal study on plasma and glomerular eluates. Clin Exp Immunol 1996;105:132-9.
15. van Bruggen MCJ, Kramers C, Walgreen B, et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant 1997;12:57-66.
16. Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 2003;48:2888-97.
17. Amoura Z, Piette JC, Chabre H, et al. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum anti-nucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum 1997;40:2217-25.
18. Amoura Z, Koutouzov S, Chabre H, et al. Presence of anti-nucleosome autoantibodies in a restricted set of connective tissue diseases: anti-nucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 2000;43:76-84.
19. Cervera R, Viñas O, Ramos Casals M, et al. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 2003;62:431-4.
20. Benucci M, Gobbi FL, Del Rosso A, Cessaretti S, Niccoli L, Cantini F. Disease activity and anti-nucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol 2003;32:42-5.
21. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
22. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
23. Urowitz MB, Gladman DD, Tozman EC, Goldsmith CH. The Lupus Activity Criteria Count (LAAC). J Rheumatol 1984;11:783-7.
24. Hawker G, Gabriel S, Bombardier C, Goldsmith C, Caron D, Gladman D. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. J Rheumatol 1993;20:657-60.
25. Chabre H, Amoura Z, Piette JC, Godeau P, Bach JF, Koutouzov S. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1995;38:1485-91.
26. Yager TD, McMurray CT, van Holde KE. Salt-induced release of DNA from nucleosome core particles. Biochemistry 1989;28:2271-81.
27. Koutouzov S, Cabrespines A, Amoura Z, Chabre H, Lotton C, Bach JF. Binding of nucleosome to a cell surface receptor: redistribution and endocytosis in the presence of lupus antibodies. Eur J Immunol 1996;26:472-86.
28. Burlingame RW, Rubin RL. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods 1990;134:187-99.
29. Min DJ, Kim SJ, Park SH, et al. Anti-nucleosome antibody significance in lupus patients lacking anti-double stranded DNA antibody. Clin Exp Rheumatol 2002;20:13-8.
30. Mohan C, Liu F, Xie C, Williams RC. Anti-subnucleosome reactivities in systemic lupus erythematosus patients and their first-degree relatives. Clin Exp Immunol 2001;123:119-26.
31. Ghillani-Dalbin P, Amoura Z, Cacoub P, et al. Testing for anti-nucleosome antibodies in daily practice: a monocentric evaluation in 1696 patients. Lupus 2003;12:833-7.
32. Cairns AP, McMillan SA, Crockard AD, et al. Anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus. Ann Rheum Dis 2003;62:272-3.
33. Riboldi P, Gerosa M, Moroni G, et al. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? Autoimmunity 2005;38:39-45.
34. Janyapoon K, Jivakanont P, Surbrsing R, Siriprapapan W, Tachawuttiwat T, Korbsrisate S. Detection of anti-dsDNA by ELISA using different sources of antigens. Pathology 2005;37:63-8.
35. Rubin RL, Bell SA, Burlingame RW. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J Clin Invest 1992;90:165-73.